Christian Schulze Shares New Data from DANGERSHOCK
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn:
”New data from DANGERSHOCK – Delay in mechanical support in pts with cardiogenic shock following AMI results in higher mortality compared to early initiation.
Great team work from the trial investigators.”
Microaxial flow pump (mAFP) support has been shown to improve survival in selected patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock.
This study investigated whether the time interval between symptom onset and randomization affects the survival benefit associated with mAFP use.
The findings aim to clarify the importance of early intervention when considering mechanical circulatory support in this high-risk population.
Read the full article here.
Article: Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial
Authors: Lisette Okkels Jensen, Rasmus Paulin Beske, Hans Eiskjær, Norman Mangner, Amin Polzin, P. Christian Schulze, Carsten Skurk, Peter Nordbeck, Peter Clemmensen, Vasileios Panoulas, Sebastian Zimmer, Andreas Schäfer et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin
-
Jan 12, 2026, 15:07Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored